GW Pharmaceuticals (GWPH)
107.50
-1.90 -1.74%
NASDAQ
Oct 20, 16:59
Delayed 2m
USD
View All Key Stats
GWPH Key Stats
| Income Statement | |
| Revenue (TTM) | 9.846M |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -5.393 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -135.74M |
| Profitability | |
| Gross Profit Margin (Quarterly) | 53.98% |
| Profit Margin (Quarterly) | -1.67K% |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 2.723B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | 274.09 |
| PE Ratio (TTM) | -- |
| Price to Book Value | 6.625 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | 0.00 |
| Free Cash Flow (Quarterly) | -20.11M |
| Return on Equity (TTM) | -32.02% |
View All GWPH News
GWPH News
-
WireHeadlineTime (ET)
-
MT Newswires10/20 10:58
-
Yahoo10/20 08:21
-
Yahoo10/18 15:54
-
PR Newswire10/16 09:00
-
MT Newswires10/13 10:40
-
Yahoo10/13 08:21
-
MT Newswires10/12 10:45
-
PR Newswire10/11 09:00
-
PR Newswire10/10 09:55
-
MT Newswires10/09 08:32
View All Events
GWPH Events
| Date | Type | Description |
|---|---|---|
| 08/07/2018 | Misc | GW Pharmaceuticals PLC Third Quarter Earnings Conference Call in 2018 |
| 08/07/2018 | Earnings | GW Pharmaceuticals PLC Third Quarter Earnings Results in 2018 |
| 05/09/2018 | Misc | GW Pharmaceuticals PLC Second Quarter Earnings Conference Call in 2018 |
| 05/09/2018 | Earnings | GW Pharmaceuticals PLC Second Quarter Earnings Results in 2018 |
| 04/20/2018 | Misc | GW Pharmaceuticals PLC Annual General Meeting in 2017 |
| 02/07/2018 | Misc | GW Pharmaceuticals PLC First Quarter Earnings Conference Call in 2018 |
| 02/07/2018 | Earnings | GW Pharmaceuticals PLC First Quarter Earnings Results in 2018 |
| 12/05/2017 | Misc | GW Pharmaceuticals PLC Fourth Quarter Earnings Conference Call in 2017 |
| 12/05/2017 | Earnings | GW Pharmaceuticals PLC Fourth Quarter Earnings Results in 2017 |
| 08/07/2017 16:30 EDT | Misc | GW Pharmaceuticals PLC Third Quarter Earnings Conference Call in 2017 |
GWPH Fundamentals
Income Statement View Statement
GWPH Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
GWPH One Page Reports
- One Page Report Download
GWPH Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 107.50 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.gwpharm.com
- Investor Relations URL: http://ir.gwpharm.com/
- HQ State/Province: N/A
- Sector: Healthcare
- Industry: Drug Manufacturers - Major
- Equity Style: Mid Cap/Blend
- Next Earnings Release: Dec. 05, 2017
- Last Earnings Release: Aug. 07, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: GW Pharmaceuticals PLC is engaged in the research, development and commercialisation of cannabinoid prescription medicines using botanical extracts derived from the Cannabis Sativa plant.
GWPH Comparables
EditGWPH Excel Add-In Codes
- Name: =YCI("GWPH","name")
- Description: =YCI("GWPH","description")
- Sector: =YCI("GWPH","sector")
- Industry: =YCI("GWPH","industry")
- Est. Current Fiscal Year End: =YCI("GWPH","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other GWPH Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- GWPH Tweets Stocktwits
Advertisement
